Analyst Research

Report Title Price
Provider: Wright Reports
Provider: Reuters Investment Profile
Provider: GlobalData
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Corgenix Medical Corp announces CE mark notification for TxBCardio assay

Thursday, 15 May 2014 09:15am EDT 

Corgenix Medical Corp:Announced in collaboration with Randox Laboratories that Randox has been granted CE Mark notification for its TxBCardio Assay.TxBCardio test measures urinary levels of the thromboxane metabolite 11dhTxB2 to determine aspirin effect in apparently healthy individuals.CE mark designation enables commercial marketing and distribution of the product in Europe. 

Company Quote

10 Sep 2014